Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Wessel

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Medical Research and Opinion|October 9, 2002
Nitrous oxide modulator: lubeluzoleHans-Christoph Diener, Thomas C Wessel
The Journal of Clinical Psychiatry|January 7, 2011
A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depressionMaurizio Fava, Kendyl Schaefer, Holly Huang, et al.
Sleep|February 16, 2006
A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomniaMartin Scharf, Milton Erman, Russell Rosenberg, et al.
Sleep|December 6, 2003
Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomniaAndrew D Krystal, James K Walsh, Eugene Laska, et al.
Sleep|August 19, 2007
Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitationsJames K Walsh, Andrew D Krystal, David A Amato, et al.
Molecular Medicine (Cambridge, Mass.)|November 19, 2002
Erythropoietin therapy for acute stroke is both safe and beneficialHannelore Ehrenreich, Martin Hasselblatt, Christoph Dembowski, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Medical Research and Opinion|October 9, 2002
Nitrous oxide modulator: lubeluzoleHans-Christoph Diener, Thomas C Wessel
The Journal of Clinical Psychiatry|January 7, 2011
A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depressionMaurizio Fava, Kendyl Schaefer, Holly Huang, et al.
Sleep|February 16, 2006
A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomniaMartin Scharf, Milton Erman, Russell Rosenberg, et al.
Sleep|December 6, 2003
Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomniaAndrew D Krystal, James K Walsh, Eugene Laska, et al.
Sleep|August 19, 2007
Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitationsJames K Walsh, Andrew D Krystal, David A Amato, et al.
Molecular Medicine (Cambridge, Mass.)|November 19, 2002
Erythropoietin therapy for acute stroke is both safe and beneficialHannelore Ehrenreich, Martin Hasselblatt, Christoph Dembowski, et al.
Pageof 1